ResearcherInsermActive in the last 2 years
Fanny Jaulin
Matched on ORCID iD 0000-0002-5110-1800; OpenAlex author ID A5075442626. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2024: 2 papers · 2025: 1 paper
Papers 3
- Pan-RAS inhibitor after KRASG12C treatment in pancreatic cancer? Co-author DOI 10.1016/j.ejca.2025.115588↗
- Codon-specific KRAS mutations predict survival in advanced pancreatic cancer. Co-author DOI 10.1016/j.esmogo.2023.100030↗
- Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2024.05.032↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alice Boilève · 3 shared papers, 2024–2025 · strength 0.63
- Paper Pan-RAS inhibitor after KRASG12C treatment in pancreatic cancer? DOI 10.1016/j.ejca.2025.115588↗
- Paper Codon-specific KRAS mutations predict survival in advanced pancreatic cancer. DOI 10.1016/j.esmogo.2023.100030↗
- Paper Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer. DOI 10.1053/j.gastro.2024.05.032↗
- Michel Pierre Ducreux · 3 shared papers, 2024–2025 · strength 0.63
- Paper Pan-RAS inhibitor after KRASG12C treatment in pancreatic cancer? DOI 10.1016/j.ejca.2025.115588↗
- Paper Codon-specific KRAS mutations predict survival in advanced pancreatic cancer. DOI 10.1016/j.esmogo.2023.100030↗
- Paper Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer. DOI 10.1053/j.gastro.2024.05.032↗
- Léa Swales · 1 shared paper, 2025 · strength 0.33
- Anthony Tarabay · 2 shared papers, 2024 · strength 0.30
- Cristina Smolenschi · 2 shared papers, 2024 · strength 0.30
- David Malka · 2 shared papers, 2024 · strength 0.30
- Antoîne Italiano · 2 shared papers, 2024 · strength 0.30
- Antoine Hollebecque · 2 shared papers, 2024 · strength 0.30
- Marc Hilmi · 1 shared paper, 2024 · strength 0.15
- Rémy Nicolle · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.